Incept LLC
3
43M
3
1
- Stages of investment
- Areas of investment
Summary
The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the Incept LLC, startups are often financed by Sante Ventures, Lightstone Ventures, Easton Capital. The meaningful sponsors for the fund in investment in the same round are Sante Ventures, Rock Springs Capital, Lightstone Ventures.
We can highlight the next thriving fund investment areas, such as Health Care, Medical Device. Among the various public portfolio startups of the fund, we may underline Claret Medical Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.
The top activity for fund was in 2017. Despite it in 2019 the fund had an activity. The fund is generally included in less than 2 deals every year. The increased amount of exits for fund were in 2018. The common things for fund are deals in the range of 10 - 50 millions dollars.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Exits
- 1
- Investments by industry
- Medical Device (3)
- Medical (2)
- Health Care (2)
- Biotechnology (1)
- Commercial (1)
- Investments by region
-
- United States (3)
- Peak activity year
- 2017
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Avg. valuation at time of investment
- 90M
- Group Appearance index
- 1.00
- Avg. company exit year
- 9
- Avg. multiplicator
- 6.55
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Instylla | 15 Aug 2023 | Biotechnology, Commercial, Medical Device | Late Stage Venture | 30M | United States, Massachusetts |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.